(MedPage Today) — Makers of a supplement marketed as a male sexual enhancement product issued a voluntary recall of the product after an FDA analysis found undeclared traces of sulfoaildenafil, an analog to the erectile dysfunction drug sildenafil.
No Comments »
Filed under: General Health News
(MedPage Today) — The maker of the prostate cancer immunotherapy sipuleucel-T (Provenge) has exaggerated the therapy’s efficacy and played down its risks in some marketing materials, the FDA charged.
No Comments »
Filed under: General Health News
(MedPage Today) — Older patients account for a majority of physician office visits, which increasingly involve specialists who treat chronic conditions, according to government statistics.
No Comments »
Filed under: General Health News
(MedPage Today) — Makers of a supplement marketed as a male sexual enhancement product issued a voluntary recall of the product after an FDA analysis found undeclared traces of sulfoaildenafil, an analog to the erectile dysfunction drug sildenafil.
No Comments »
Filed under: Pharmacy News
CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners and Pappas Ventures all participated in the financing. CeNeRx plans to use the proceeds [...]
No Comments »
Filed under: Pharmacy News
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and six months ended June 30, 2010. For the second quarter of 2010, the Company reported a net loss of $6.4 million, compared with a net loss [...]
No Comments »
Filed under: Pharmacy News
In a move likely to secure its place as a leading provider of medical radiation countermeasures, Humanetics Corporation today announced that it has secured exclusive worldwide licenses to two new treatments that provide short and long-term post-exposure protection from ionizing radiation acquired during a terrorist act, nuclear or radiological attack or accident, as part of [...]
No Comments »
Filed under: Pharmacy News
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.
No Comments »
Filed under: Pharmacy News
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported second quarter financial results and highlighted the clinical progress of its in-house programs.
No Comments »
Filed under: Pharmacy News
Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.0 million financing with two existing institutional shareholders, both of which are affiliates of Xmark Opportunity Partners, LLC.
No Comments »
Filed under: Pharmacy News
